An in vitro culture of human fetal hepatocytes has been employed for infection by hepatitis B virus (HBV) virions that are produced by an established human hepatoma cell line, HB 611. HBV surface antigen and e antigen were released into the medium 3-4 days after infection, and production continued thereafter. RNA synthesis with similar kinetics was observed. Viral DNA replication started 2 days after infection, and replicative HBV DNA that included relaxed circles, single-stranded minus strands, and closed circles accumulated during 16 days of incubation. Immunofluorescent study using fluorescein isothiocyanate-labeled rabbit antisera directed against HBV core antigen revealed that this antigen is present in the nuclei in 12% of the infected cells. Particles containing HBV DNA were detected in the culture medium and were infectious. Thus, this in vitro infection system closely mimics infection in vivo and it allows detailed studies on early events associated with human HBV entry into cells and subsequent replication and integration.
Hepatitis B virus (HBV) is a world-wide pathogen that causes hepatitis. Infection with the virus may be chronic and is associated with subsequent development of hepatocellular carcinoma. Although chimpanzees can be infected in vivo with HBV (1) and woodchucks, ground squirrels, and Peking ducks can be infected with their respective HBV-like viruses (2) (3) (4) , use of whole animals poses certain limitations for detailed molecular studies. The most vexing technical problem in the biology of HBV has been lack of a practical in vitro system that allows infection and replication of this virus under controlled experimental conditions. Several investigators have attempted to infect human hepatic cells by using human adult and fetal hepatocytes (5, 6) , fetal hepatocyte organ culture (7) , oval cells originating from human liver (8) , and HeLa cells (6) . However, no signs of viral penetration, replication, or particle production have been observed except for a transient expression of some viral markers.
We have established a cell line (HB 611) derived from a human hepatocellular carcinoma cell line (Huh6c15) by transfecting with a plasmid containing tandemly arranged HBV DNA. The HB 611 cells carry chromosomally integrated HBV genomes, and they allow expression of viral RNA, DNA, and proteins and produce Dane-particle-like virions (9) . These particles have all the properties characteristic of the Dane particles from the patient's blood (10) . However, it has not yet been proved that the virions are actually infectious. Although the chromosomally integrated HBV genomes in the HB 611 cells allow viral replication, the replicative intermediates differ from those observed with the infected liver in that the closed circular form of HBV DNA was not detectable in HB 611 cells. Transfection of Hep G2 and Huh 7 derivatives, both from human hepatomas, showed the same effect (11, 12) . In (14), glucose-6-phosphatase (15) , and y-glutamyl transpeptidase (16) , were performed with unfixed cells. Albumin secretion into the medium was measured by using enzyme-linked immunoadsorbent assay (ELISA) (17) .
Detection of HBV Surface Antigen (HBsAg) and HBV e Antigen (HBeAg). HBsAg and HBeAg were assayed in culture medium by using commercial enzyme immunoassay (EIA) kits (Abbott) (9) . Titers were expressed as the ratios against cut-off values (A492 of negative control + 0.06 for HBsAg and + 0.05 for HBeAg).
Detection of HBV Core Antigen (HBcAg) by Immunofluorescent Staining. The cells were fixed in acetone at 40C, treated with a proper dilution of polyclonal human antibody against HBcAg (6) , and stained with fluorescein isothiocyanate (FITC)-conjugated rabbit anti-human globulin.
DNA and RNA Preparations from Hepatocytes. Extrachromosomal DNA was prepared as described by Hirt (18) . The cells were lysed in 0.5 M NaCl/10 mM Tris HCl, pH 7.4/1 mM EDTA/1% sodium dodecyl sulfate and stored overnight at 40C. Cellular DNA was pelleted at 16,000 x g for 60 min, and the extrachromosomal DNA recovered in the supernatant was incubated at 370C for 1 hr with Pronase E (Wako Pure Chemical, Osaka, Japan, 1 mg/ml), treated with phenol/chloroform, and precipitated with ethanol. The DNA was dissolved in 10 mM Tris HCl, pH 7.4/1 mM EDTA. Total RNA was extracted by homogenizing cells in guanidine thiocyanate and sedimenting them through a layer of 5.7 M CsCl as described elsewhere (9) .
Purification of Virus Particles. Viral particles produced and released from the HBV-infected hepatocytes into culture medium at 4-12 days of infection were purified by CsCl density gradient centrifugation (9) .
Hybridization Studies. DNAs were subjected to electrophoresis in 1.5% agarose, transferred to a nitrocellulose filter, and analyzed as described by Southern (19) . RNAs were subjected to electrophoresis in a 1.0% agarose gel containing 6.6% formaldehyde, blotted onto nitrocellulose filters, and analyzed as described by Maniatis et al. (20) . Hybridization was done under stringent conditions with random-primed 32P-labeled whole HBV DNA probe prepared from pBRHBadr4 (21) (specific activity, >2 x 108 cpm/,ug).
RESULTS

Properties of the Hepatocytes Isolated from Human Fetal
Liver. Human hepatocytes were prepared from fetal liver at 20-24 weeks of gestation, and 2 x 106 cells were plated on collagen-coated plastic plate (60-mm diameter) to make monolayers. Two hours after plating, the hepatocytes started to attach to the dish and began to flatten. Twenty-four hours after the plating, subconfluent monolayers were obtained. Most of the hepatocytes thus obtained were mononuclear, polyhedral, and arranged in trabeculae. At 7 days of culture greater than 95% of these plated cells were histochemically positive for glycogen, glucose-6-phosphatase, and y-glutamyl transpeptidase. These regular morphologies and biochemical characteristics were well retained for at least 2 weeks of subsequent culture, and an outgrowth of fibroblastic or oval cells was not detected. Albumin secretion in the medium of the cultured hepatocytes was detected 2 days after the plating and continued for 16 days (Fig. 1) . The albumin was maximal at 10-12 days after plating and leveled off thereafter.
Production of Viral Antigens in Cells Infected with HBV. Coculture infection was designed to provide independent access to two different cell layers: HB 611 cells, which produce HBV virions, were seeded in the upper layer, and the fetal hepatocytes were in the bottom layer. Thus, fresh virus particles were supplied as they were made. In the first experiment, primary fetal hepatocytes at 24 weeks of gestation (2 x 106 cells in 3 ml of 10% FCS/DMEM) were cultured for 7 days on the plate and then cocultured for 3 days with monolayered HB 611 cells (1 x 106 cells per well) that were producing approximately 1 x 107 virions during the coculture. After the infection, the HB 611 cells were removed and the hepatocytes were washed three times with DMEM and further incubated in 3 ml of 10% FCS/DMEM (time zero). The culture medium was collected periodically during this incubation and the levels of HBsAg and HBeAg were analyzed. As shown in Fig. 2 , the HBV-specific proteins were first detected 4 days after the infection and continued to increase during the 2 weeks of incubation. They must have been synthesized de novo, because they appeared only after 4 days ofincubation. Thus, the human fetal hepatocytes were likely to be infected by virions and were propagating HBV. We chose the time of HBV challenge (7 days Proc. Natl. Acad. Sci. USA 86 (1989) Detection of Virus-Specific Transcripts. Total RNA was prepared from the cultured hepatocytes at day 12 after infection, when HBsAg and HBeAg were detected in the culture fluid. It was then subjected to Northern blot analyses using whole HBV DNA as a probe. Three major transcripts, approximately 3.6, 2.4, and 2.1 kilobases (kb) were detected (Fig. 3) , in complete agreement with those detected in the liver of infected HBV (22) and in the cultured HBV-producing cells (9) . The 3.6-kb mRNA represents the whole genome transcript, and is believed to serve as a pregenome for viral DNA replication (23) . Other two mRNA species (2.4 and 2.1 kb) apparently correspond to the transcripts that are translated into large and small HBsAg (24) . None ofthe bands were detected after RNase digestion or in noninfected cells. Thus, this system is actively producing HBV-encoded RNAs.
Replicative HBV DNA in Extrachromosomal Form. To see if HBV DNA was replicating in the human fetal hepatocytes, cells were harvested at various times after infection. Extrachromosomal DNA was then extracted according to Hirt and analyzed by Southern blotting using 32P-labeled whole HBV DNA as a probe. If HBV DNA was replicating in our system, the replicative HBV DNAs would have to be recovered in this fraction (9) . As shown in Fig. 4 , virus-specific DNA replicative intermediates appeared 2 days after infection. These DNA molecules cannot be carryovers of the infecting virions, because no DNA was detectable in cells or on cell surfaces at 0 or 1 day after the infection. In the 6-day sample, three replicative DNA components (termed D, CC, and S) could be identified. The S component had the size of singlestranded viral (minus strand) DNA. It did not change upon heating, hybridized only to the plus strand probe, and was not cleaved by BamHI. Thus this component must be the singlestranded DNA, as expected. The D component had the mobility expected for the partially single-stranded, relaxedcircular viral DNA (9) , and the CC component had the mobility expected for the covalently closed circular (CCC) form of HBV DNA. It shifted to the 3.2-kb position after digestion with BamHI (25), and it was maintained upon heating at 950C for 5 min (Fig. 4, lane B) . Thus, we concluded that the CC component must be the HBV DNA in CCC form. With increasing time after infection, these replicative DNA molecules accumulated. Their accumulation, especially accumulation of the CCC form, has been reported in the active infected human liver (26) never been detected in cultured human hepatoma cell lines that were transfected by HBV DNA and allowed its replication. Therefore, our experimental infection system not only allows infection by the HBV virion but also reproduces the full cycle of viral replication.
Viral DNA in the Culture Medium. Our preliminary surveys detected the HBV DNA in the culture medium. Because they were not detected at time zero, they must have been released from the infected hepatocytes. To characterize these DNA molecules, the culture media were collected from day 0 to day 3 and from day 4 to day 12, and particles were collected by using a CsCI density-gradient centrifugation. DNA was extracted from the purified particles and subjected to Southern blot analyses (Fig. 5) . Particles prepared from the culture medium 4-12 days after infection were found to contain mostly the D form of HBV DNA (Fig. 5, lane b) , whereas there was no HBV DNA in the culture medium at 0-3 days after infection (Fig. 5, lane a) Northern blot analysis of total RNA from infected cells.
Total RNA was extracted from cells at day 12 after infection and subjected to Northern hybridization using whole HBV DNA as a probe. Numbers show size of RNA species in kb. .s-J". the 6-day culture about 5 x 106 particles per ml were contained in the medium.
Reinfection by the Extracellular Virus Particles. To learn whether the virus particles released from the infected cells were infectious, the culture media at 4-16 days after the infection were pooled and about 1-2 x 107 particles in 1.0 ml of medium were added to another primary human fetal hepatocyte culture at the 7th day of plating (hepatocytes received 10-20 virions per cell). After 3 hr of incubation at 370C the inoculum was removed and the cells were washed and cultured with 10% FCS/DMEM. The culture medium was harvested at 0, 4, and 8 days after the infection and tested for HBsAg and HBeAg. The results (Table 1) show that virus-specific antigens started to appear at 4 days after the second infection and increased thereafter. The mode of production of virus-specific antigens and relative infectivity were almost superimposable to those observed in the coculturing experiments using HB 611 cells. Because no viral antigens were detected in culture medium at time zero, these virus-specific antigens cannot be carryovers of the inocula. These results demonstrate that infectious viruses were in fact produced and released into the medium of the infected hepatocytes and that the infection can be achieved by virions in culture medium, without coculturing with HB 611 cells.
To characterize the infectious agent in the culture medium, we determined whether antibodies specific for viral proteins would block infectivity. The culture medium of infected cells was incubated with rabbit antibodies directed against HBsAg (anti-HBsAg) and against HBcAg (anti-HBcAg) and then the media were assayed for infectivity. The anti-HBsAg antibodies reduced the infectivity, whereas anti-HBcAg antibodies or normal rabbit serum did not (data not shown). Although we have not examined the infectious agents by electron microscopy, these results suggest that they are most likely to be Dane-particle-like bodies coated with surface antigen.
Detection of HBcAg in the Infected Hepatocytes by Immunofluorescent Staining. To estimate the population of infected cells, immunofluorescence assay was performed with polyclonal human antibody against HBcAg, taking advantage of the fact that the viral core proteins accumulate exclusively within the infected cells. Core antigens were detected in 10-12% of the cells 6 days after infection (Fig. 6) , whereas no core antigens were detected in the uninfected cells (data not shown). Only nuclei were stained in the infected cells. The percentage of positive cells did not increase 12 days after infection (data not shown), even though the production of viral antigens and viral replication in the culture reached the maximum at this stage (Figs. 2 and 4) , suggesting that spreading of virus to neighboring cells does not take place in this system.
DISCUSSION
Experimental transmission of HBV can be achieved in chimpanzees. However, many attempts to establish an in vitro system that allows infection by the virion have not been successful. Recently, replication of HBV in human hepatoma cell lines by using integrated or transfected HBV genomes as template has been achieved (9, 11, 12 Our in vitro experimental infection system will also be useful for detailed studies of HBV infection and replication, which have not been elucidated in molecular terms. For example, the process of virus attachment and entry into cells, the subsequent early reactions that occur in replication, and integration of virus DNA into host chromosomes may be the targets for next studies. In this connection, it may be of some interest to point out that HBV DNA in CCC form has not been found in other cultured cell systems, so far as we know.
After this paper was written a paper by Gripon et al. (28) appeared that reported infection and replication of HBV in some preparations of cultured adult human hepatocytes.
